XML 38 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity (Tables)
 9 Months Ended
Oct. 03, 2021
Equity [Abstract]  
Earnings (Loss) per share The following table sets forth the computation of basic and diluted earnings/(loss) per share:
Three Months EndedNine Months Ended
October 3, 2021September 27, 2020October 3, 2021September 27, 2020
Numerator:
Net income/(loss) attributable to Sonoco$111,140 $83,449 $(150,634)$219,105 
Denominator:
Weighted average common shares outstanding:
Basic98,955 100,974 100,039 100,935 
Dilutive effect of stock-based compensation470 271 — 220 
Diluted99,425 101,245 100,039 101,155 
Net income/(loss) attributable to Sonoco per common share:
Basic$1.12 $0.83 $(1.51)$2.17 
Diluted$1.12 $0.82 $(1.51)$2.17 
Cash dividends$0.45 $0.43 $1.35 $1.29 
Schedule of antidilutive securities excluded from computation of earnings per share The average numbers of SARs that were anti-dilutive and, therefore, not included in the computation of diluted earnings per share during the three- and nine-month periods ended October 3, 2021 and September 27, 2020 were as follows:
Three Months EndedNine Months Ended
October 3, 2021September 27, 2020October 3, 2021September 27, 2020
Anti-dilutive stock appreciation rights— 752 142 844 
The following table sets forth the potentially dilutive securities excluded from the computation of diluted net loss per share during the nine-month period ended October 3, 2021:
Nine Months Ended
October 3, 2021
Dilutive securities excluded due to reported loss469